Pavion Blue Capital’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-740
Closed -$234K 102
2024
Q3
$234K Sell
740
-30
-4% -$10.7K 0.11% 97
2024
Q2
$288K Sell
770
-55
-7% -$18.6K 0.14% 79
2024
Q1
$286K Sell
825
-39
-5% -$14.8K 0.14% 79
2023
Q4
$396K Hold
864
0.22% 66
2023
Q3
$420K Hold
864
0.26% 61
2023
Q2
$386K Sell
864
-20
-2% -$10.1K 0.23% 67
2023
Q1
$429K Sell
884
-45
-5% -$22.2K 0.26% 65
2022
Q4
$476K Hold
929
0.3% 61
2022
Q3
$451K Hold
929
0.32% 59
2022
Q2
$435K Hold
929
0.29% 59
2022
Q1
$404K Buy
+929
New +$389K 0.24% 62

Other funds holding HUM

Pavion Blue Capital's HUM Position: Q4 2024 in Review

Pavion Blue Capital sold out of Humana (HUM) in Q4 2024, closing a stake of 740 shares — an estimated $234K sold.

Pavion Blue Capital first reported a position in HUM in Q1 2022 and held it in 11 quarters. The position peaked at $476K in Q4 2022. 877 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Pavion Blue Capital reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Pavion Blue Capital sold 740 Humana shares in Q4 2024, an estimated $234K.
  • Pavion Blue Capital first reported a position in Humana in Q1 2022 and held it in 11 quarters.
  • Pavion Blue Capital's Humana position peaked at $476K in Q4 2022.
  • 877 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Pavion Blue Capital's 13F filing for Q4 2024, filed 4 Feb 2025.